Timberlyne Therapeutics
Durham, United States· Est.
Timberlyne Therapeutics is a biotech company developing novel small molecule therapies for neurodegenerative diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $180M
About
Timberlyne Therapeutics is a biotech company developing novel small molecule therapies for neurodegenerative diseases.
NeuroscienceSmall Molecules
Funding History
1Total raised:$180M
Series A$180M